Physician profile
Jonelle George
NPI 1700226693
$1,466.45
in general payments reported to CMS, 2019-2025
14 companies · $26.45 in 2025
The $26.45 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.25 · 2020: $97.56 · 2021: $716 · 2022: $373 · 2023: $129 · 2024: $30.66 · 2025: $26.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $517.85 | 2020-2022 | |
| Boston Scientific Corporation | $223.74 | 2019-2021 | |
| Angiodynamics, INC. | $128.88 | 2023 | Auryon Laser System 100-120 Vac |
| Gilead Sciences, INC. | $117.26 | 2021-2022 | |
| Cardiovascular Systems INC. | $102.94 | 2021 | |
| Mallinckrodt Hospital Products INC. | $86.88 | 2021 | |
| Pfizer INC. | $55.98 | 2021-2022 | |
| Janssen Biotech, INC. | $54.26 | 2022 | |
| Braintree Laboratories, INC. | $52.29 | 2021-2022 | |
| Celgene Corporation | $42.65 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $30.66 | 2024 | Rebyota |
| Genzyme Corporation | $26.45 | 2025 | |
| Abbvie INC. | $14.57 | 2022 | |
| Redhill Biopharma INC. | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonelle George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.